InMed Pharmaceuticals (INM) Other Non-Current Assets (2020 - 2026)

InMed Pharmaceuticals' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $104368.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 4.37% year-over-year to $104368.0 in Q1 2026; TTM through Mar 2026 was $104368.0, a 4.37% increase from a year earlier, with the FY2025 full-year figure at $100000.0, changed 0.0% from the prior year.
• Other Non-Current Assets rose to $104368.0 in Q1 2026 per INM's latest filing, from $100000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $176637.0 in Q2 2022 and bottomed at $100000.0 in Q4 2023.
• The 5-year median for Other Non-Current Assets is $100000.0 (2023), against an average of $116828.1.
• Across the five-year window, Other Non-Current Assets surged 1884.12% in 2022 and plunged 41.56% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $171130.0 in 2022, then plunged by 41.56% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then grew by 4.37% to $104368.0 in 2026.
• Per Business Quant, the three latest INM Other Non-Current Assets figures stand at $104368.0 (Q1 2026), $100000.0 (Q4 2025), and $100000.0 (Q3 2025).